These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6386039)
1. The expression of Ca antigen in normal, hyperplastic and neoplastic endometrium. Ferguson AM; Fox H Br J Obstet Gynaecol; 1984 Oct; 91(10):1042-5. PubMed ID: 6386039 [TBL] [Abstract][Full Text] [Related]
2. Distribution of epithelial membrane antigen in normal and abnormal endometrial tissue. Morse AR; Curran GJ Br J Obstet Gynaecol; 1985 Dec; 92(12):1286-90. PubMed ID: 3910081 [TBL] [Abstract][Full Text] [Related]
3. Immunodetection of sialyl-Tn antigen in normal, hyperplastic and cancerous tissues of the uterine endometrium. Inoue M; Ogawa H; Tanizawa O; Kobayashi Y; Tsujimoto M; Tsujimura T Virchows Arch A Pathol Anat Histopathol; 1991; 418(2):157-62. PubMed ID: 1899958 [TBL] [Abstract][Full Text] [Related]
4. CA 19-9, CA 125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma. Neunteufel W; Breitenecker G Cancer Lett; 1989 Nov; 48(1):77-83. PubMed ID: 2684391 [TBL] [Abstract][Full Text] [Related]
5. Human milk-fat globule membrane antigens (Mam-3 group) in normal cycling endometrium and endometrial carcinomas--an immunohistochemical study. A preliminary report. Ravn V; Jensen H; Hilgers J APMIS; 1989 May; 97(5):452-8. PubMed ID: 2659045 [TBL] [Abstract][Full Text] [Related]
6. Patterns of reactivity with the monoclonal antibodies HMFG1 and HMFG2 in normal endometrium, endometrial hyperplasia and adenocarcinoma. Morris WP; Griffin NR; Wells M Histopathology; 1989 Aug; 15(2):179-86. PubMed ID: 2476372 [TBL] [Abstract][Full Text] [Related]
7. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614 [TBL] [Abstract][Full Text] [Related]
8. CA 125 and CA 19-9 immunolocalization in normal, hyperplastic, and carcinomatous endometrium. Podczaski E; Kaminski PF; Zaino R Cancer; 1993 Apr; 71(8):2551-6. PubMed ID: 8453578 [TBL] [Abstract][Full Text] [Related]
9. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Afify AM; Craig S; Paulino AF; Stern R Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159 [TBL] [Abstract][Full Text] [Related]
10. Expression of CAR-3 and TAG-72 macromolecules in normal and transformed endometrium: potential diagnostic application in postmenopausal patients. Bartolazzi A; Mottolese M; Vocaturo A; Bigotti A; Vocaturo G; Atlante G; Prat M; Natali PG Cancer Res; 1991 Jun; 51(11):3001-5. PubMed ID: 2032237 [TBL] [Abstract][Full Text] [Related]
11. Thomsen-Friedenreich-related antigen in human endometrium. An immunohistochemical study employing the monoclonal antibody 49H.8. A preliminary report. Ravn V; Jensen H APMIS; 1988 Jun; 96(6):552-8. PubMed ID: 3293628 [TBL] [Abstract][Full Text] [Related]
12. Simple mucin-type carbohydrates in normal and malignant human endometrium. Ravn V; Mandel U; Svenstrup B; Dabelsteen E Int J Gynecol Pathol; 1995 Apr; 14(2):158-66. PubMed ID: 8601528 [TBL] [Abstract][Full Text] [Related]
13. [Detection of carcinoembryonic antigen of endometrial carcinoma and hyperplasia]. Shen JB Zhonghua Fu Chan Ke Za Zhi; 1990 Jan; 25(1):29-30, 62. PubMed ID: 2182309 [TBL] [Abstract][Full Text] [Related]
14. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge. Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463 [TBL] [Abstract][Full Text] [Related]
15. [Preliminary study on detecting the CA 125 value in endometrial washings]. Chen DX; Schwartz PE Zhonghua Fu Chan Ke Za Zhi; 1987 Sep; 22(5):288-90, 312. PubMed ID: 3481694 [No Abstract] [Full Text] [Related]
16. Expression of carcinoembryonic antigen and ferritin in normal, hyperplastic, and neoplastic endometrium. Tsionou C; Minaretzis D; Papageorgiou I; Nakopoulou L; Michalas S; Aravantinos D Gynecol Oncol; 1991 Jun; 41(3):193-8. PubMed ID: 1869094 [TBL] [Abstract][Full Text] [Related]
17. Use of monoclonal antibodies MSN-1 and B72.3 in the prediction of the natural history of endometrial hyperplasia. Schwartz AM; Silverberg SG; Fu YS; Nozawa S; Huang S; Tsukasaki K; Williams KR Int J Gynecol Pathol; 1993 Jul; 12(3):253-8. PubMed ID: 8344762 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma. Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738 [TBL] [Abstract][Full Text] [Related]
19. Oestrogen receptor in glands and stroma of normal and neoplastic human endometrium: a combined biochemical, immunohistochemical, and morphometric study. Thornton JG; Wells M J Clin Pathol; 1987 Dec; 40(12):1437-42. PubMed ID: 3323252 [TBL] [Abstract][Full Text] [Related]
20. [Finding antigens using immunoenzyme methods characterized by nonhistone proteins in hyperplastic and neoplastic endometrium in women]. Miturski R Ginekol Pol; 1995 May; 66(5):277-9. PubMed ID: 8522224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]